March 31, 2026 · Form 4 insider transaction
Beneski Benjamin Machinas sold 2,867 shares of Allogene Therapeutics, Inc. at $2.50 per share, a transaction worth $7.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.